Amatera Bioscience
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Amatera Bioscience - overview
Established
2022
Location
Boulogne Billancourt, -, France
Primary Industry
Agribusiness
About
Based in Paris, France, and founded in 2022, Amatera Bioscience provides technology solutions for coffee plants. As of 2023, the company is headed by its CEO Omar Dekkiche. In March 2026, Amatera Bioscience raised EUR 6 million in seed funding co-led by Demea Invest and Oyster Bay, with participation from PINC, Mudcake, and Exceptional Ventures. The company by leveraging non-GMO technology creates coffee varieties.
The firm product range includes naturally caffeine-free coffee which eliminates the chemical and polluting decaffeination processes. Additionally, it also offers robustica which is a climate-resistant product with arabica cup quality. In order to create fresh and enhanced perennial crop types, it also collaborates with agrifood businesses and research facilities. The company will use the March 2026 funding to scale its breeding platform and move beyond coffee and wine grapes.
Current Investors
AgFunder, Joyance Partners, Mudcake
Primary Industry
Agribusiness
Sub Industries
Crop Production
Website
www.amatera.bio
Verticals
Agtech
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.